CareDx (CDNA) Common Equity (2013 - 2026)

CareDx has disclosed Common Equity across 14 years of filings, most recently posting $425.6 million for Q2 2026.

• In Q2 2026, Common Equity rose 30.01% year-over-year to $425.6 million; the TTM figure through Jun 2026 stood at $425.6 million (up 30.01% YoY), while the FY2025 annual figure was $303.1 million, down 19.91% from the prior year.
• Common Equity came in at $425.6 million for Q2 2026 at CareDx, up from $313.5 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $457.5 million in Q1 2022 to a low of $256.2 million in Q1 2024.
• Average Common Equity over 5 years is $360.1 million, with a median of $378.9 million recorded in 2024.
• Year-over-year, Common Equity tumbled 39.35% in 2023 and soared 48.05% in 2025.
• Over 5 years, Common Equity stood at $430.9 million in 2022, then plunged by 39.35% to $261.3 million in 2023, then soared by 44.81% to $378.4 million in 2024, then fell by 19.91% to $303.1 million in 2025, then soared by 40.41% to $425.6 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $425.6 million in Q2 2026, $313.5 million in Q1 2026, and $303.1 million in Q4 2025.